Why It Matters
Kentucky’s aggressive expansion of substance abuse treatment under Governor Andy Beshear helped reduce overdose deaths for four straight years, but the state’s decision to remove safeguards on Medicaid approvals created an opening for widespread fraud that cost taxpayers $2.3 billion in a single year and is now forcing treatment capacity to contract sharply.
What Happened
When Beshear took office in December 2020, Kentucky was grappling with twin crises: the COVID-19 pandemic and a rising overdose death toll. The governor’s administration lifted restrictions that had required insurers to approve substance abuse treatment before providers began services, a move designed to expand access quickly. More than 40 other states followed similar paths during the same period.
The policy worked. By 2023, Kentucky had established over 1,100 long-term residential treatment spots—a state record. Overdose deaths fell for four consecutive years. But the removal of approval requirements also created vulnerability to fraud.
Addiction Recovery Care, Kentucky’s largest treatment provider and the state’s biggest recipient of addiction-treatment funds from 2019 to 2025, capitalized on the looser oversight. At its peak, ARC served roughly one-third of Kentuckians seeking drug treatment. More than half of the services it billed Medicaid for were lower-level peer support services rather than licensed professional interventions.
In February 2025, Kentucky Medicaid Commissioner Lisa Lee disclosed that “the previous year’s spending on behavioral health and addiction treatment had reached an unprecedented $2.3 billion.” By December 2025, the state attorney general’s office identified Medicaid fraud in drug treatment as its primary area of concern, as first reported by the Kentucky Lantern.
An FBI investigation lasting two years culminated in a $16 million Department of Justice settlement with ARC in 2025 over allegations of Medicaid fraud. The settlement, based on a 2023 whistleblower lawsuit filed by three former ARC employees, alleged that the company directed staff to falsely bill Medicaid for peer support services. ARC resolved the allegations without admitting liability.
Separately, ARC leader Tim Robinson was indicted on charges of wire fraud and money laundering related to a scheme to defraud lenders. He pleaded not guilty.
The fallout has been severe. ARC was forced to close most of its facilities over two years, triggering a 56 percent decline in long-term residential treatment beds statewide—erasing much of the expansion that made Kentucky a national leader in treatment access.
By the Numbers
$2.3 billion — behavioral health and addiction treatment spending in the year before February 2025
1,100+ — long-term residential treatment spots available in Kentucky by 2023
Four — consecutive years of overdose death declines (2020–2025)
One-third — proportion of Kentucky’s drug treatment clients served by ARC at its peak
$16 million — Department of Justice settlement with ARC over Medicaid fraud allegations
56% — decline in long-term residential treatment beds statewide after ARC facility closures
Zoom Out
Kentucky’s experience mirrors a broader tension in Medicaid policy. Removing administrative barriers accelerates access to care in emergencies—and the state’s four-year overdose decline suggests the policy saved lives. But loosened oversight also attracts what Stuart Owen, a Kentucky Medicaid insurer employee, described as “unscrupulous providers” willing to exploit weak billing controls. By 2024, health industry experts were warning that treatment providers across multiple states were billing excessively for subpar care. Unlike Kentucky, most states that lifted Medicaid treatment restrictions during the pandemic restored prior approval requirements by 2023. Kentucky did not.
What’s Next
Republicans in the Kentucky legislature responded in 2025 by passing a bill requiring treatment centers to seek insurer approval before beginning services—effectively reimposing the safeguard the state had removed five years earlier. Governor Beshear, when asked about the expansion’s costs, noted the counterfactual: “If we’d gone back in time too early and changed things too drastically, how many more people would have died that we’ve saved?” The state now faces the challenge of rebuilding treatment capacity while preventing future fraud—a balancing act that will test whether stricter oversight can coexist with broad access, as first reported by the Kentucky Lantern.